# No Reverse Transcriptase Control in RT-qPCR: Why It Is Essential and How to Use It

## Key Takeaways

- The no reverse transcriptase (no-RT) control is indispensable in RT-qPCR to detect genomic DNA (gDNA) contamination in RNA samples, which can lead to false-positive results in gene expression studies and viral RNA detection.
- This control is established by running an RT-qPCR reaction with all components except the reverse transcriptase enzyme; amplification in this reaction unequivocally indicates the presence of amplifiable gDNA.
- Essential for all RNA-based gene expression analyses, viral RNA detection, and RNA quantification, the no-RT control is typically run in duplicate or triplicate alongside experimental samples.
- Amplification in the no-RT control, particularly with a Cq value within 5 cycles of the experimental RT reaction, signifies significant gDNA contamination, rendering the quantitative data unreliable and necessitating repeat experiments, often after DNase treatment.
- While intron-spanning primers can mitigate gDNA amplification, they do not entirely obviate the need for no-RT controls due to potential issues like processed pseudogenes or alternative splicing events.
- The interpretation of no-RT control results is quantitative, with a ΔCq (Cq_noRT - Cq_RT) of less than 5 cycles indicating substantial contamination, while a ΔCq greater than 10 suggests very low contamination, with specific thresholds guiding data usability.

---

The no reverse transcriptase (no-RT) control, also called the minus RT control or NRT control, is a critical experimental control in reverse transcription quantitative PCR (RT-qPCR) that detects genomic DNA (gDNA) contamination in RNA samples. It consists of a reaction containing all RT-qPCR components except the reverse transcriptase enzyme. If amplification occurs in this control, it indicates that the measured signal originates from contaminating gDNA rather than from the target RNA, invalidating the quantification. The no-RT control is essential whenever RNA is extracted from cellular or tissue sources, as gDNA is frequently co-purified during RNA isolation and can produce false-positive results in downstream [qPCR analysis](/knowledge/diagnostics/molecular/qpcr-analysis-plate-layout-delta-delta-ct).

## At a Glance

| Aspect | Description |
|--------|-------------|
| **Purpose** | Detect genomic DNA contamination in RNA samples |
| **Setup** | Identical to RT-qPCR reaction but without reverse transcriptase enzyme |
| **Expected result** | No amplification (Cq > detection limit or no signal) |
| **Interpretation** | Amplification indicates gDNA contamination; data may be unreliable |
| **When essential** | All RNA-based gene expression studies, viral RNA detection, and [RNA quantification](/knowledge/diagnostics/molecular/rna-quantification-methods-spectrophotometry-fluorometry) |
| **When optional** | When samples are DNase-treated and validated as gDNA-free, or when using intron-spanning primers |
| **Common pitfalls** | Using water instead of RNA template, insufficient replicates, ignoring late Cq values |

## Scientific Principle: Why Genomic DNA Contamination Matters

Reverse transcription quantitative PCR (RT-qPCR) is designed to quantify RNA molecules by first converting them to complementary DNA (cDNA) using reverse transcriptase, then amplifying the cDNA by PCR. The fundamental problem is that reverse transcriptase enzymes can also use DNA as a template, though with lower efficiency than RNA [<a href="#ref-1">1</a>]. More critically, if genomic DNA is present in the RNA sample, it can serve as a direct template for the PCR step, producing amplification products that are indistinguishable from those derived from the target RNA.

The consequences of undetected gDNA contamination are severe. In gene expression studies, gDNA contamination inflates apparent transcript levels, leading to false conclusions about gene regulation. For viral RNA detection, gDNA contamination can produce false-positive results with serious diagnostic implications. The magnitude of this problem depends on several factors: the abundance of the target gene in the genome, the efficiency of the PCR primers, and the amount of gDNA present relative to the target RNA.

Genomic DNA contamination is particularly problematic for genes that have processed pseudogenes in the genome. Processed pseudogenes are non-functional copies of genes that lack introns and are derived from retrotransposition events. Because they lack introns, primers designed to span exon-exon junctions may still amplify pseudogene sequences from gDNA, producing false signals. Even when primers are carefully designed, gDNA contamination can produce amplification from intron-containing regions if the PCR product is short enough to be amplified from the gDNA template.

The no-RT control directly addresses this problem by providing a baseline measurement of gDNA-derived signal. Since the control reaction lacks reverse transcriptase, any amplification must come from DNA templates present in the RNA sample. This allows researchers to distinguish between true RNA-derived signals and artifacts of gDNA contamination.

## Materials and Instrumentation Considerations

### RNA Sample Requirements

The no-RT control requires the same RNA sample that will be used for the RT-qPCR experiment. The RNA should be extracted using methods that minimize gDNA carryover. Common RNA extraction methods include:

- **Column-based purification**: Silica membrane columns that include on-column DNase treatment steps
- **Organic extraction**: Phenol-chloroform extraction followed by ethanol precipitation
- **Magnetic bead-based purification**: Bead-based RNA capture methods

Each method has different efficiencies for removing gDNA. Column-based methods with DNase treatment typically remove most gDNA, but residual contamination can still occur, especially with high-input samples. Organic extraction methods are less effective at removing gDNA and often require post-extraction DNase treatment.

### Reverse Transcriptase Enzyme Selection

The choice of reverse transcriptase affects the no-RT control interpretation. Some reverse transcriptases have higher affinity for DNA templates than others. For example, the Bordetella phage BPP-1 DGR reverse transcriptase (bRT) has been shown to have distinct error profiles and template preferences [<a href="#ref-1">1</a>]. While most commercial reverse transcriptases are optimized for RNA templates, their ability to use DNA templates varies.

When selecting a reverse transcriptase, consider:

- **Thermostability**: Higher temperature reactions reduce secondary structure and may affect gDNA amplification
- **Processivity**: Enzymes with higher processivity may be more likely to extend from DNA primers annealed to gDNA
- **RNase H activity**: Some enzymes have RNase H activity that degrades RNA in RNA-DNA hybrids, potentially affecting cDNA yield

### Primer Design and Selection

Primer design significantly impacts the ability of the no-RT control to detect gDNA contamination. Key considerations include:

- **Intron-spanning primers**: Primers that span exon-exon junctions will only amplify from cDNA, not from gDNA (which contains introns). However, this design does not eliminate the need for no-RT controls because pseudogenes and alternative splicing can complicate interpretation.
- **Intron-flanking primers**: Primers that flank an intron will produce different-sized products from cDNA (smaller) and gDNA (larger). This allows gel-based discrimination but complicates qPCR analysis.
- **Amplicon length**: Shorter amplicons (<150 bp) are more likely to amplify from gDNA because they are less affected by DNA secondary structure and degradation.

### Instrumentation and Reagent Systems

Different qPCR instruments and reagent systems have varying sensitivities to gDNA contamination. Key factors include:

- **Detection chemistry**: SYBR Green-based detection is more susceptible to gDNA contamination because it binds any double-stranded DNA, including primer-dimers and non-specific products. Probe-based detection (TaqMan, molecular beacons) is more specific but can still detect gDNA if the probe binding site is present in the genome.
- **Instrument sensitivity**: More sensitive instruments may detect lower levels of gDNA contamination, making the no-RT control more critical.
- **Master mix composition**: Some commercial RT-qPCR master mixes include components that suppress gDNA amplification, while others do not.

## Control Setup and Experimental Design

### Basic No-RT Control Setup

The no-RT control reaction should contain:

1. **RNA template**: The same RNA sample used for the RT reaction
2. **Primers**: The same forward and reverse primers used for the target gene
3. **qPCR master mix**: The same PCR master mix used for the experimental reactions
4. **Water**: To replace the reverse transcriptase enzyme volume
5. **Optional**: RNase inhibitor to prevent RNA degradation during setup

The reaction should be set up in parallel with the RT reaction, using the same RNA dilution and the same thermal cycling conditions. The only difference is the absence of reverse transcriptase.

### Replicate Strategy

For reliable interpretation, the no-RT control should be run in at least duplicate, preferably triplicate. This allows assessment of technical variability and helps distinguish true amplification from sporadic contamination. The number of replicates should match the number used for experimental samples to allow direct comparison of variability.

### Including No-RT Controls for Multiple Genes

When analyzing multiple target genes, a separate no-RT control should be included for each target. This is because different primer pairs have different sensitivities to gDNA contamination. A primer pair that amplifies a highly repetitive genomic region may show strong gDNA signal, while a primer pair targeting a single-copy gene may show none.

### No-RT Control for Multiple Samples

For experiments with many samples, it is not necessary to run no-RT controls for every sample. A practical approach is:

- **Pooled no-RT control**: Combine equal amounts of RNA from all samples and use this pool for the no-RT control
- **Representative samples**: Select samples expected to have the highest gDNA contamination (e.g., samples with high cell numbers or from tissues with high DNA content)
- **Random sampling**: Include no-RT controls for 10-20% of samples, selected randomly

However, if any no-RT control shows amplification, all samples from that experiment should be considered potentially contaminated.

## Conceptual Workflow

### Step 1: RNA Extraction and Quality Assessment

Extract RNA using your chosen method. Assess RNA quality by:
- **Spectrophotometry**: Measure A260/A280 ratio (should be 1.8-2.0 for pure RNA) and A260/A230 ratio (should be >1.8)
- **Gel electrophoresis**: Check for [ribosomal RNA](/knowledge/bioinformatics/ribosomal-rna-structure-taxonomic-profiling) bands (28S and 18S in eukaryotes)
- **Microfluidic analysis**: Use Bioanalyzer or similar for [RNA integrity number](/knowledge/diagnostics/molecular/rna-integrity-assessment-rin-values-gel-electrophoresis) (RIN)

### Step 2: DNase Treatment (Optional but Recommended)

If gDNA contamination is expected or detected, treat RNA samples with DNase I. This step should be performed after RNA extraction and before RT-qPCR. DNase treatment protocols vary by manufacturer but typically involve:
- Incubating RNA with DNase I at 37°C for 15-30 minutes
- Inactivating DNase by heat (65°C for 10 minutes) or by adding chelating agents
- Purifying RNA again to remove DNase and reaction components

### Step 3: Prepare RT and No-RT Reactions

Set up two reaction mixes for each sample:

**RT reaction mix** (per reaction):
- RNA template (typically 10-100 ng)
- Reverse transcriptase enzyme
- Reaction buffer
- dNTPs
- Primers (random hexamers, oligo-dT, or gene-specific)
- RNase inhibitor
- Nuclease-free water to final volume

**No-RT control mix** (per reaction):
- RNA template (same amount as RT reaction)
- Nuclease-free water (to replace reverse transcriptase)
- Reaction buffer
- dNTPs
- Primers (same as RT reaction)
- RNase inhibitor
- Nuclease-free water to final volume

### Step 4: Perform Reverse Transcription

Incubate both RT and no-RT reactions under identical conditions:
- Primer annealing: 25°C for 5-10 minutes (for random hexamers) or 37°C for 15 minutes (for oligo-dT)
- Reverse transcription: 42-50°C for 30-60 minutes (depending on enzyme)
- Enzyme inactivation: 70-85°C for 5-15 minutes

### Step 5: Perform qPCR

Use the cDNA from the RT reaction and the no-RT control as templates for qPCR:
- Set up qPCR reactions with the same master mix and primers
- Include no-template controls (NTC) to detect reagent contamination
- Run on the same plate to ensure identical cycling conditions

### Step 6: Analyze Results

Compare Cq values between RT and no-RT reactions:
- **No amplification in no-RT**: RNA is free of detectable gDNA contamination
- **Amplification in no-RT with Cq >5 cycles later than RT**: Low-level contamination; data may be usable with caution
- **Amplification in no-RT with Cq within 5 cycles of RT**: Significant contamination; data are unreliable

## Quality Checks and Validation

### Acceptance Criteria for No-RT Controls

The no-RT control should meet the following criteria for the experiment to be considered valid:

1. **No amplification**: The no-RT control should show no amplification curve or a Cq value above the detection limit (typically >35-40 cycles)
2. **No specific product**: Melt curve analysis (for SYBR Green) should show no peak corresponding to the target amplicon
3. **Consistent results across replicates**: All replicates should show similar results

### Distinguishing True Amplification from Artifacts

Not all amplification in no-RT controls indicates gDNA contamination. Consider these possibilities:

- **Primer-dimer formation**: Can produce amplification in late cycles, especially with SYBR Green detection
- **Reagent contamination**: Contaminated water or master mix can produce false signals
- **Carryover contamination**: Amplicon from previous experiments can contaminate new reactions

To distinguish these, include a no-template control (NTC) that contains water instead of RNA. If the NTC shows amplification, the problem is reagent contamination, not gDNA contamination.

### Validation Experiments

For new primer sets or sample types, perform validation experiments:

1. **Spike-in experiment**: Add known amounts of gDNA to RNA samples and measure recovery in no-RT controls
2. **DNase treatment comparison**: Compare no-RT results before and after DNase treatment
3. **Primer specificity test**: Test primers on purified gDNA to determine their amplification efficiency

## Result Interpretation

### Quantitative Interpretation

The Cq difference between RT and no-RT reactions (ΔCq = Cq_noRT - Cq_RT) provides information about the level of gDNA contamination:

| ΔCq Value | Interpretation | Action Required |
|-----------|----------------|-----------------|
| No amplification in no-RT | No detectable gDNA contamination | Proceed with analysis |
| ΔCq > 10 | Very low contamination | Data likely usable; report ΔCq |
| ΔCq 5-10 | Low contamination | Use caution; consider DNase treatment |
| ΔCq < 5 | Significant contamination | Data unreliable; repeat with DNase treatment |
| ΔCq = 0-2 | Severe contamination | Data invalid; repeat experiment |

### Qualitative Interpretation

For presence/absence assays (e.g., viral RNA detection), the no-RT control is even more critical. If the no-RT control shows amplification, the sample cannot be confidently called positive for the target RNA. In such cases:

- **If no-RT is positive and RT is positive**: The result is ambiguous; gDNA contamination cannot be ruled out
- **If no-RT is negative and RT is positive**: The result supports RNA-specific detection
- **If both are negative**: The sample is negative for the target

### Reporting Results

When reporting RT-qPCR results, include:

- Cq values for both RT and no-RT reactions
- ΔCq values for each sample
- Whether DNase treatment was performed
- Any corrective actions taken

## Troubleshooting

| Observation | Likely Cause | Discriminating Check |
|-------------|--------------|----------------------|
| No-RT control shows amplification at Cq < 35 | Genomic DNA contamination | Run no-RT control with DNase-treated RNA; if amplification disappears, gDNA is confirmed |
| No-RT control shows amplification at Cq > 35 | Low-level gDNA contamination or primer-dimer | Perform melt curve analysis; check for non-specific products |
| No-RT control shows amplification but NTC does not | gDNA contamination specific to RNA sample | Repeat with fresh RNA aliquot; treat with DNase |
| Both no-RT and NTC show amplification | Reagent contamination | Replace water, master mix, and primers; clean work area |
| No-RT control shows inconsistent amplification across replicates | Stochastic contamination or pipetting error | Increase replicates; use master mix instead of individual components |
| No-RT control shows amplification only with certain primer sets | Primer-specific gDNA amplification | Redesign primers to span exon-exon junctions or introns |
| No-RT control shows amplification after DNase treatment | Incomplete DNase digestion or DNase contamination | Increase DNase concentration or incubation time; purify RNA after DNase treatment |
| No-RT control shows amplification with SYBR Green but not with probes | Non-specific binding in SYBR Green | Confirm with probe-based assay; perform melt curve analysis |

## Limitations and Considerations

### When No-RT Controls May Not Be Sufficient

The no-RT control has several limitations:

1. **Does not detect all contamination types**: It only detects gDNA that can be amplified by the specific primer pair used. Different primer pairs may detect different levels of contamination.
2. **Cannot distinguish between gDNA and cDNA**: If the no-RT control shows amplification, it cannot determine whether the signal comes from gDNA or from cDNA that was present in the RNA sample (e.g., from previous experiments).
3. **Sensitivity limitations**: Very low levels of gDNA contamination may not be detected, especially with short amplicons or inefficient primers.
4. **Does not account for reverse transcriptase activity on DNA**: Some reverse transcriptases can use DNA as a template, producing cDNA from gDNA during the RT step. This would not be detected by the no-RT control.

### Alternative and Complementary Approaches

Several approaches can complement or replace the no-RT control:

1. **DNase treatment**: Enzymatic removal of gDNA before RT-qPCR
2. **Intron-spanning primers**: Primers that cannot amplify gDNA
3. **RNA-only extraction controls**: Process a sample without cells to detect reagent contamination
4. **Genomic DNA spike-in controls**: Add known amounts of gDNA to monitor removal efficiency

### When No-RT Controls Are Optional

The no-RT control may be omitted when:

- Samples have been validated as gDNA-free by multiple methods
- Using intron-spanning primers that have been tested on gDNA and shown no amplification
- Working with RNA that has been extensively purified and DNase-treated
- The experimental question does not require absolute quantification

However, even in these cases, periodic no-RT controls are recommended to confirm that contamination has not occurred.

## Documentation and Reporting Standards

### What to Document

For each experiment, document:

1. **Sample information**: Source, extraction method, RNA concentration and purity
2. **DNase treatment**: Enzyme used, concentration, incubation conditions
3. **RT reaction**: Enzyme, primers, temperature, time
4. **qPCR conditions**: Master mix, primers, instrument, cycling parameters
5. **No-RT control results**: Cq values, melt curves, interpretation
6. **Corrective actions**: Any steps taken to address contamination

### MIQE Guidelines Compliance

The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines recommend including no-RT controls in all RT-qPCR experiments. When publishing results, report:

- Whether no-RT controls were included
- The number of no-RT controls per experiment
- The results of no-RT controls (Cq values or "no amplification")
- Any corrective actions taken based on no-RT results

### Data Archiving

Store raw data including:
- Amplification curves for all reactions
- Melt curves (for SYBR Green)
- Cq values with standard deviations
- Plate layouts showing well assignments

## Biosafety Considerations

### BSL-1 Laboratory Practices

For routine RT-qPCR work with non-pathogenic organisms, follow standard BSL-1 practices as outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [<a href="#ref-2">2</a>]:

- Work in a clean, uncluttered area
- Use dedicated pipettes for RNA work
- Wear gloves and lab coat
- Decontaminate work surfaces before and after use
- Dispose of RNA samples and reaction mixes as biohazardous waste

### RNA Handling Precautions

RNA is susceptible to degradation by RNases, which are ubiquitous in the environment. To maintain RNA integrity:

- Use RNase-free water and reagents
- Treat work surfaces with RNase decontamination solutions
- Use filter pipette tips
- Keep RNA samples on ice during handling
- Store RNA at -80°C for long-term storage

### Preventing Cross-Contamination

To prevent contamination of no-RT controls:

- Set up RT and no-RT reactions in separate areas
- Use separate pipettes for RNA and PCR reagents
- Change gloves between handling different samples
- Include no-template controls to detect reagent contamination
- Use aerosol-resistant pipette tips

### Recombinant Nucleic Acid Considerations

If working with recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [<a href="#ref-3">3</a>]. This may require:

- Institutional Biosafety Committee (IBC) approval
- Registration of the work with the institutional biosafety office
- Use of appropriate containment levels

## Frequently Asked Questions

### 1. Can I use the same no-RT control for multiple target genes?

No, you should include a separate no-RT control for each target gene. Different primer pairs have different sensitivities to genomic DNA contamination. A primer pair that amplifies a repetitive genomic region may show strong gDNA signal, while a primer pair targeting a single-copy gene may show none. Using a single no-RT control for all targets could miss contamination that affects only specific primer sets.

### 2. What should I do if my no-RT control shows amplification but my NTC does not?

This indicates genomic DNA contamination in your RNA sample. The first step is to treat the RNA sample with DNase I and repeat the no-RT control. If the amplification disappears, the contamination was from gDNA. If it persists, consider that the contamination might be from carryover of cDNA from previous experiments. In either case, the experimental data from that sample should be interpreted with caution or discarded.

### 3. How many cycles of Cq difference between RT and no-RT is acceptable?

There is no universal cutoff, but a commonly used guideline is that the no-RT control should have a Cq value at least 5 cycles higher than the RT reaction. A ΔCq of 5 corresponds to approximately 32-fold difference in template amount (assuming 100% PCR efficiency). If the ΔCq is less than 5, the gDNA contribution to the RT signal is significant and the data are unreliable. For absolute quantification, a ΔCq of 10 or more is recommended.

### 4. Can I use a no-RT control if I am using a one-step RT-qPCR kit?

Yes, one-step RT-qPCR kits still require a no-RT control. In one-step reactions, the reverse transcriptase and PCR components are combined in a single tube. To create a no-RT control, simply omit the reverse transcriptase enzyme from the reaction mix. However, be aware that some one-step kits contain reverse transcriptase in the master mix, making it impossible to create a true no-RT control. In such cases, you must use a two-step approach or a different kit for the control.

## Related Clinical & Scientific Guides

* [Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of African Swine Fever Virus in Oral Fluids](/knowledge/diagnostics/molecular/lamp-assay-rapid-detection-african-swine-fever-virus-oral-fluids)
* [How to Calculate the Concentration of Protein Using the Lowry Assay](/knowledge/diagnostics/molecular/calculate-protein-concentration-lowry-assay)
* [DNA Extraction from Saliva: Non-Invasive Sampling and Protocols](/knowledge/diagnostics/molecular/dna-extraction-saliva-non-invasive-sampling-protocols)

## References and Further Reading

<a id="ref-1"></a>[<a href="#ref-1">1</a>] [High-throughput analyses of a reconstituted diversity-generating retroelement identify intrinsic and extrinsic determinants of diversification](https://pubmed.ncbi.nlm.nih.gov/41642819/) - Unlu I, Smiley MK, Potapov V, et al. (2026). Provides context on reverse transcriptase template preferences and error profiles relevant to understanding RT enzyme behavior in no-RT controls.

<a id="ref-2"></a>[<a href="#ref-2">2</a>] [Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition](https://www.cdc.gov/labs/bmbl/index.html) - CDC and NIH (2020). Authoritative principles for risk assessment and laboratory practice.

<a id="ref-3"></a>[<a href="#ref-3">3</a>] [NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules](https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/) - National Institutes of Health. Institutional and biosafety framework for nucleic acid research.

<a id="ref-4"></a>[<a href="#ref-4">4</a>] [Telomeres control human telomerase (TERT) expression through non-telomeric TRF2](https://pubmed.ncbi.nlm.nih.gov/41026782/) - Sengupta A, Vinayagamurthy S, Soni D, et al. (2025). Demonstrates RT-qPCR methodology for gene expression analysis with appropriate controls.

<a id="ref-5"></a>[<a href="#ref-5">5</a>] [Ear tissue as a diagnostic sample for pestivirus detection in semi-domesticated Eurasian tundra reindeer in Norway](https://pubmed.ncbi.nlm.nih.gov/41356484/) - Malmström E, Tryland M, Passler T, et al. (2025). Illustrates practical application of RT-PCR and RT-qPCR for viral RNA detection with control considerations.

<a id="ref-6"></a>[<a href="#ref-6">6</a>] [The good, the bad, and the stable: Reference genes for preclinical biodistribution studies](https://pubmed.ncbi.nlm.nih.gov/42147442/) - Mackeben K, Müller S, Dolim K, et al. (2026). Discusses normalization strategies and quality control in RT-dPCR, relevant to understanding control requirements.

<a id="ref-7"></a>[<a href="#ref-7">7</a>] [NCBI Bookshelf: Molecular Biology and Laboratory Methods](https://www.ncbi.nlm.nih.gov/books/) - National Center for Biotechnology Information. Searchable collection of authoritative methods references.

## Related Articles

- [Controls in qPCR: No Template Control, No Reverse Transcriptase Control, and Positive Control](/knowledge/diagnostics/molecular/controls-in-qpcr-ntc-nrt-positive)
- [RT-qPCR vs qPCR: When to Use Each Method](/knowledge/diagnostics/molecular/rt-qpcr-vs-qpcr-when-to-use)
- [qPCR Efficiency: Why It Matters and How to Improve It](/knowledge/diagnostics/molecular/qpcr-efficiency-improvement)
- [Reverse Transcription Quantitative PCR (RT-qPCR): Principles and Workflow](/knowledge/diagnostics/molecular/rt-qpcr-principles-workflow)
- [No Template Control (NTC) in qPCR: Setup, Interpretation, and Troubleshooting](/knowledge/diagnostics/molecular/no-template-control-ntc-qpcr-setup-interpretation-troubleshooting)
- [Understanding No Template Control (NTC) Amplification in qPCR: Causes and Solutions](/knowledge/diagnostics/molecular/understanding-no-template-control-ntc-amplification-in-qpcr-causes-and-solutions)


<div data-calculator="qpcr"></div>